Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nature Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11590442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adoptive cellular therapy.

  2000cited by this paper
• Allogeneic vaccination for renal cell carcinoma: development and monitoring

  2000cited by this paper
• CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

  2000cited by this paper
• Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

  2000cited by this paper
• Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells

  1999cited by this paper
• Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf) and Cd40 Ligand Genes Take up and Present Endogenous Tumor-Associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte Response

  1999cited by this paper
• Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes

  1998cited by this paper
• The role of CD4+ T cell responses in antitumor immunity.

  1998cited by this paper
• Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.

  1998cited by this paper
• Prospects for adoptive T cell therapy.

  1997cited by this paper
• Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy

  1997cited by this paper
• Phenotypic Analysis of Antigen-Specific T Lymphocytes

  1996cited by this paper
• The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

  1996cited by this paper
• Principles for adoptive T cell therapy of human viral diseases.

  1995cited by this paper
• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

  1995cited by this paper
• Cellular immune response to human renal‐cell carcinomas: Definition of a common antigen recognized by HLA‐A2‐restricted cytotoxic T‐Lymphocyte (CTL) clones

  1994cited by this paper
• Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

  1991cited by this paper
• The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells.

  1990cited by this paper

• Single-cell RNA and TCR repertoire analysis identify markers of virus-specific T cells.

  2025cites this paper
• Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy

  2025cites this paper
• Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell

  2024cites this paper
• Tyrosinase-Related Protein2 Peptide with Replacement of N-Terminus Residue by Cysteine Binds to H-2Kb and Induces Antigen-Specific Cytotoxic T Lymphocytes after Conjugation with CpG-DNA.

  2023cites this paper
• Modification of the antigenicity of cancer cells by conjugates consisting of hyaluronic acid and foreign antigens.

  2023cites this paper
• Epstein‒Barr virus-associated cellular immunotherapy.

  2023cites this paper
• THE GENERATION AND APPLICATION OF ANTIGEN-SPECIFIC T CELL THERAPIES FOR CANCER AND VIRAL-ASSOCIATED DISEASE.

  2022cites this paper
• Deciphering Repertoire of B16 Melanoma Reactive TCRs by Immunization, In Vitro Restimulation and Sequencing of IFNγ-Secreting T Cells

  2021influential citation
• Empirical and Rational Design of T Cell Receptor-Based Immunotherapies

  2021cites this paper
• Simultaneous monitoring assay for T-cell receptor stimulation-dependent activation of CD4 and CD8 T cells using inducible markers on the cell surface.

  2021cites this paper
• Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells

  2020cites this paper
• Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal

  2020cites this paper
• Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain

  2019cites this paper
• T cell engineered with a novel nanobody‐based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy

  2019cites this paper
• Targeted Delivery of IL2 to the Tumor Stroma Potentiates the Action of Immune Checkpoint Inhibitors by Preferential Activation of NK and CD8+ T Cells

  2019cites this paper
• Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells

  2019cites this paper
• NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death

  2018cites this paper
• Übertragung des koff-rate-Assays an CD8+ zytotoxischen T-Zellen vom murinen auf das humane System

  2018cites this paper
• Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: “Doublet Technology”

  2018cites this paper
• Interleukin‐15 and cisplatin co‐encapsulated thermosensitive polypeptide hydrogels for combined immuno‐chemotherapy

  2017cites this paper
• Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy

  2017cites this paper
• The untold story of IFN-γ in cancer biology.

  2016cites this paper
• Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression

  2016cites this paper
• Engineering nanoscale surface features to sustain microparticle rolling in flow.

  2015cites this paper
• Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.

  2015cites this paper
• Tumor‐infiltrating lymphocytes for the treatment of metastatic cancer

  2015cites this paper
• Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.

  2015cites this paper
• A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.

  2015cites this paper
• Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation.

  2014cites this paper
• Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity

  2014cites this paper
• Cytokine-like molecule CCDC134 contributes to CD8⁺ T-cell effector functions in cancer immunotherapy.

  2014cites this paper
• MHC multimer purification of rare antigen specific T cells and direct T cell receptor isolation by single cell PCR

  2014cites this paper
• PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.

  2014cites this paper
• Complementation of Antigen-presenting Cells to Generate T Lymphocytes With Broad Target Specificity

  2014cites this paper
• Effector Functions in Cancer Immunotherapy T-cell + Cytokine-like Molecule CCDC 134 Contributes to CD 8

  2014cites this paper
• Antitumor efficacy of argon–helium cryoablation-generated dendritic cell vaccine in glioma

  2014cites this paper
• Characterisation of high and low avidity peptide specific CD8+ T cells using immunologic, transcriptomic and proteomic tools

  2013cites this paper
• Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.

  2013cites this paper
• HCMV-specific T-cell Therapy: Do Not Forget Supply of Help

  2013cites this paper
• Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.

  2013cites this paper
• New approaches to graft engineering for haploidentical bone marrow transplantation.

  2012cites this paper
• T Cells + Role of CD4 IL-2 Receptor Signaling Pathway: The Key Memory T Cells by Partial Targeting of the Virus-Specific Multifunctional Central Preferential Expansion of Human

  2012cites this paper
• Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells

  2012cites this paper
• Preferential Expansion of Human Virus-Specific Multifunctional Central Memory T Cells by Partial Targeting of the IL-2 Receptor Signaling Pathway: The Key Role of CD4+ T Cells

  2012cites this paper
• Current translational and clinical practices in hematopoietic cell and gene therapy.

  2012cites this paper
• Efficiency and Mechanism of Antigen-specific CD8+ T-cell Activation Using Synthetic Long Peptides

  2012cites this paper
• Cancer Immunotherapy and Nanomedicine

  2011cites this paper
• Exploiting antitumor immunity to overcome relapse and improve remission duration

  2011cites this paper
• An experimental study of dendritic cells transfected with cancer stem-like cells RNA against 9L brain tumors

  2011cites this paper
• In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia

  2011cites this paper
• Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy

  2010cites this paper
• Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.

  2010cites this paper
• Adoptive Therapy Using Antigen-Specific T-Cell Clones

  2010cites this paper
• Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

  2010cites this paper
• Small but mighty: How the MACS®‐technology based on nanosized superparamagnetic particles has helped to analyze the immune system within the last 20 years

  2010cites this paper
• Evaluating maturation and genetic modification of human dendritic cells in a new polyolefin cell culture bag system

  2010cites this paper
• Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies.

  2010cites this paper
• Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy.

  2009cites this paper
• Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients

  2009cites this paper
• Adoptive transfer of virus-specific and tumor-specific T cell immunity.

  2009cites this paper
• Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity.

  2009cites this paper
• Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.

  2009cites this paper
• In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells

  2009cites this paper
• Development ofTumor-ReactiveTCells After Nonmyeloablative Allogeneic Hematopoietic Stem CellTransplant for Chronic Lymphocytic Leukemia

  2009cites this paper
• Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia

  2009cites this paper
• In Vitro Activation of Cytotoxic T Lymphocytes By Muc1 PulsedDendritic Cells

  2009cites this paper
• Making and circumventing tolerance to cancer

  2009cites this paper
• Clinical implications of immune reconstitution following hematopoietic stem cell transplantation.

  2009cites this paper
• Adenovirus infections in solid organ transplant recipients

  2009cites this paper
• Tc17 CD8 T Cells: Functional Plasticity and Subset Diversity1

  2009cites this paper
• Graft-versus-leukemia effects of transplantation and donor lymphocytes.

  2008cites this paper
• Downregulation of IFN‐γR in association with loss of Fas function is linked to tumor progression

  2008cites this paper
• Intravital imaging of CD8+ T cell function in cancer

  2008cites this paper
• Adoptive cellular immunotherapy for childhood malignancies

  2008cites this paper
• Mechanisms of Rejection of High Grade B cell Lymphoma in Mice

  2008cites this paper
• Genetics and Molecular Biology of Tuberous Sclerosis Complex

  2008cites this paper
• Gene Gun Bombardment with DNA-Coated Gold Particles Is a Potential Alternative to Hydrodynamics-Based Transfection for Delivering Genes into Superficial Hepatocytes

  2008cites this paper
• Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.

  2008cites this paper
• Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy.

  2008cites this paper
• Tuberous sclerosis complex: disease modifiers and treatments.

  2008cites this paper
• Overcoming immune evasion in T cell therapy of cancer: lessons from animal models.

  2008cites this paper
• Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.

  2008cites this paper
• Impaired dendritic cell function in aging leads to defective antitumor immunity.

  2008cites this paper
• Antitumor effector functions of T cells are dependent on in vivo priming and restricted T‐cell receptor expression

  2008cites this paper
• Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-α gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors

  2007cites this paper
• Association between a High-Expressing Interferon-g Allele and a Lower Frequency of Kidney Angiomyolipomas in TSC 2 Patients

  2007cites this paper
• Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant.

  2007cites this paper
• Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response.

  2007cites this paper
• Capture and generation of adenovirus specific T cells for adoptive immunotherapy

  2007cites this paper
• Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70

  2007cites this paper
• Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning

  2007cites this paper
• Decreased 7,12-dimethylbenz[a]anthracene-induced carcinogenesis coincides with the induction of antitumor immunities in adult female B6C3F1 mice pretreated with genistein.

  2007cites this paper
• Early detection and rapid isolation of leukemia-reactive donor T cells for adoptive transfer using the IFN-gamma secretion assay.

  2007cites this paper
• Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.

  2007cites this paper
• Generation of EBV-specific T Cells for Adoptive Immunotherapy: A Novel Protocol Using Formalin-fixed Stimulator Cells to Increase Biosafety

  2007cites this paper
• Interferon-gamma expressing EBV LMP2A-specific T cells for cellular immunotherapy.

  2007cites this paper
• CD8(+) T cells armed with retrovirally transduced IFN-gamma.

  2007cites this paper
• Minor Histocompatibility Antigen (mHag)-specific And B-cell Chronic Lymphocytic Leukemia (CLL)- reactive T Cells Can Be Derived From Matched Sibling Donors Using Transformed CLL Cells As Stimulator Cells

  2007cites this paper
• CD8+ T cells armed with retrovirally transduced IFN-γ

  2006cites this paper
• Murine Model of Immune-Mediated Rejection of the Acute Lymphoblastic Leukemia 70Z/31

  2006cites this paper